OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The neuroimmune interface in retinal regeneration	189
In vivo application of base and prime editing to treat inherited retinal diseases	178
Vogt-Koyanagi-Harada disease under the lens: Insights from multimodal ocular imaging	175
Cell identity changes in ocular surface Epithelia	153
Widefield OCT angiography	142
International consensuses and controversies on causes, diagnosis and management of diabetic macular edema (DME)	136
Non-vasogenic cystoid maculopathies	131
Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics	120
Animal models for the evaluation of retinal stem cell therapies	117
Editorial Board	115
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	105
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	105
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	102
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	95
Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation	94
Corneal stromal repair and regeneration	88
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	88
Central serous chorioretinopathy: An evidence-based treatment guideline	85
Editorial Board	84
Myocilin misfolding and glaucoma: A 20-year update	83
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	81
Quantification of retinal microvascular imaging features from fundus photos in ocular and systemic disease: a framework for standardization	80
Risk factors, clinical features and treatment of Behçet's disease uveitis	79
Squishy matters – Corneal mechanobiology in health and disease	78
Homeostatic plasticity in the retina	78

Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	77
A paradigm shift in retinal detachment repair: The concept of integrity	77
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	76
Are Müller Glial Cells Gatekeepers of Neuroprotection and Regeneration in Age-Related Macular Degeneration? Unraveling Their Roles in Pathophysiology and Therapeutic Innovation	72
Cell fate decisions, transcription factors and signaling during early retinal development	71
Eye care adherence in pediatric and elderly: Understanding and addressing the challenges	69
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	69
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	68
Femtosecond lasers in ophthalmology: Mechanisms, clinical breakthroughs, and multidisciplinary frontiers	68
How gut microbiota may impact ocular surface homeostasis and related disorders	66
The retinal pigmentation pathway in human albinism: Not so black and white	64
RNA-targeting strategies as a platform for ocular gene therapy	60
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	59
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	57
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	56
Cellular component transfer between photoreceptor cells of the retina	56
Rhodopsin, light-sensor of vision	54
Optical coherence tomography angiography in diabetic retinopathy	54
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	53
Retinal pigment epithelium 65 kDa protein (RPE65): An update	49
Interventions to reduce incidence and progression of myopia in children and adults	49
Editorial Board	49
Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis	49
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	48
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	46
Regulation of lens water content: Effects on the physiological optics of the lens	46
Outer retinal tubulation associated with photoreceptor degeneration	46
Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality	45
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	43
Editorial Board	41
Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration	41
The march to harmonized imaging standards for retinal imaging	41
Quantitative analysis of conjunctival vascular alterations: Applications in ocular and systemic disease detection	40
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	38
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity	38
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma	36
Quantitative approaches in multimodal fundus imaging: State of the art and future perspectives	36
The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs	35
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases	35
Bacterial keratitis: identifying the areas of clinical uncertainty	35
The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies	35